# Modulatory Effects of Cirsimarin on Lung Cancer A549 Cells Migration in 2D and 3D Cultures Involves Transcriptional Regulation of Metalloproteinases

**Authors:** Anna Gabriele Prado dos Santos, Celina Yung‐Ai Lin Lee, Érica Romão Pereira, Andresa Hiromi Sakai, Diego Luís Ribeiro, Victor Antônio Silva Lima, Marcos Bispo Pinheiro Camara, Cláudia Quintino da Rocha, Sabine A. S. Langie, Ilce Mara de Syllos Cólus, Juliana Mara Serpeloni

PMC · DOI: 10.1002/jbt.70772 · Journal of Biochemical and Molecular Toxicology · 2026-03-09

## TL;DR

This study shows that cirsimarin, a flavone, inhibits lung cancer cell migration and viability in 2D and 3D models by affecting genes related to cell growth and matrix remodeling.

## Contribution

The novel contribution is the identification of cirsimarin's antimetastatic potential through transcriptional regulation of metalloproteinases in lung cancer cells.

## Key findings

- Cirsimarin reduced A549 cell viability and migration in 2D and 3D models.
- It induced apoptosis and DNA damage at specific concentrations.
- Downregulation of genes like MMP-2, MMP-9, and TP53 was observed.

## Abstract

Current toxicology and cancer biology investigations have focused on developing alternative models that better recapitulate the in vivo architecture of tissues and organs. The present study evaluated the anticancer effects of the flavone cirsimarin, which presented successful antitumor activity on breast tumor cells. We assessed the impact of flavone on cell viability, proliferation, and migration, as well as on DNA integrity and modulation of related cellular pathways. In the 2D model, cirsimarin reduced cell viability at concentrations ≥ 80 μM after 24 h of treatment (resazurin assay), selectively in A549 cells compared to MRC‐5 non‐tumor cells. Apoptosis was induced at concentrations ≥ 40 μM, and clonogenicity was reduced by approximately 50% only at 160 μM. In the wound healing assay, cirsimarin (1–80 μM) completely inhibited cell migration and induced DNA damage (comet assay). These apoptotic and anti‐migratory effects were associated with the downregulation of key genes involved in cell proliferation, death, and extracellular matrix remodeling, including TNF‐α (0.32‐fold), TP53 (0.17‐fold), MMP‐2 (0.18‐fold), MMP‐9 (0.43‐fold), and MMP‐11 (0.04‐fold), as revealed by RT‐qPCR analysis. In the 3D model, after 216 h of treatment, cirsimarin reduced cell viability (≥ 40 μM) and spheroid area (≥ 80 μM) while antimigratory effects were observed only in the highest concentration evaluated (160 μM). These findings could indicate a potential reduction in lung tumor growth and metastasis, warranting further investigation, particularly of the antimetastatic effect of this flavone.

In 2D culture, the cirsimarin (i) decreased cell viability in both assays, (ii) induced apoptosis, (iii) reduced clonogenicity, (iv) prevented cell migration, (v) induced DNA damage, and (vi) negatively modulated gene expression. In the 3D model, reductions in spheroid viability, area, and cell migration were also observed.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], TP53 (tumor protein p53) [NCBI Gene 7157], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], MMP11 (matrix metallopeptidase 11) [NCBI Gene 4320]
- **Chemicals:** cirsimarin (PubChem CID 159460)
- **Diseases:** lung cancer (MONDO:0005138)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CD55 (CD55 molecule (Cromer blood group)) [NCBI Gene 1604] {aka CHAPLE, CR, CROM, DAF, TC}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, CLDN2 (claudin 2) [NCBI Gene 9075] {aka OAZON, claudin-2}, PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, ABCC2 (ATP binding cassette subfamily C member 2) [NCBI Gene 1244] {aka ABC30, CMOAT, DJS, MRP2, cMRP}, APEH (acylaminoacyl-peptide hydrolase) [NCBI Gene 327] {aka AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, TRAF2 (TNF receptor associated factor 2) [NCBI Gene 7186] {aka MGC:45012, RNF117, TRAP, TRAP3}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, MMP11 (matrix metallopeptidase 11) [NCBI Gene 4320] {aka SL-3, ST3, STMY3}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** multidrug (MESH:D018088), mitochondrial dysfunction (MESH:D028361), breast (MESH:D061325), death (MESH:D003643), SCLC (MESH:D055752), metastases (MESH:D009362), diseases (MESH:D004194), gastrointestinal problems (MESH:D012817), inflammation (MESH:D007249), metastatic (MESH:D000092182), Cytotoxicity (MESH:D064420), LCB-N (MESH:C536108), adenocarcinoma (MESH:D000230), Cancer (MESH:D009369), Lung Cancer (MESH:D008175), neurotoxicity (MESH:D020258), PC (MESH:C536209), Smoking (MESH:D015208), breast tumor (MESH:D001943), obesity (MESH:D009765), LUAD (MESH:D000077192), squamous, and large-cell carcinomas (MESH:D002294), NSCLC (MESH:D002289), Cell (MESH:D002292), necrosis (MESH:D009336)
- **Chemicals:** fluorescein diacetate (MESH:C018506), doxorubicin (MESH:D004317), flavone (MESH:C043562), methanol (MESH:D000432), NaCl (MESH:D012965), Biochanin A. (MESH:C004541), DMEM (-), PI (MESH:D011419), Cisplatin (MESH:D002945), vinca alkaloids (MESH:D014748), etoposide (MESH:D005047), Triton X-100 (MESH:D017830), paclitaxel (MESH:D017239), quercetin-3-glucoside (MESH:C016527), vincristine (MESH:D014750), EDTA (MESH:D004492), resorufin (MESH:C014180), Hoechst 33342 (MESH:C017807), irinotecan (MESH:D000077146), N (MESH:D009584), isoflavone (MESH:D007529), vinblastine (MESH:D014747), apigenin (MESH:D047310), agarose (MESH:D012685), Ho (MESH:D006695), taxanes (MESH:D043823), CO2 (MESH:D002245), resazurin (MESH:C005843), water (MESH:D014867), NaOH (MESH:D012972), cytochalasin (MESH:D003572), ethanol (MESH:D000431), DTX (MESH:D000077143), flavonoids (MESH:D005419), DMSO (MESH:D004121), vinorelbine (MESH:D000077235), acetic acid (MESH:D019342), topotecan (MESH:D019772), p-nitrophenyl phosphate (MESH:C008644), Kuwanon C (MESH:C000629744), taxane (MESH:C080625), sodium acetate (MESH:D019346), luteolin (MESH:D047311), Cirsimarin (MESH:C107783)
- **Species:** Taxus brevifolia (Pacific yew, species) [taxon 46220], Scoparia dulcis (escobillo, species) [taxon 107240], Homo sapiens (human, species) [taxon 9606], Catharanthus roseus (chatas, species) [taxon 4058], Camptotheca acuminata (species) [taxon 16922], Bos taurus (bovine, species) [taxon 9913], Podophyllum peltatum (species) [taxon 35933]
- **Mutations:** N  12183018 A
- **Cell lines:** MRC-5 — Homo sapiens (Human), Finite cell line (CVCL_0440), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), MCTS — Mesocricetus auratus (Golden hamster), Hamster neoplasm, Cancer cell line (CVCL_Y446), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12972608/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12972608/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC12972608/full.md

---
Source: https://tomesphere.com/paper/PMC12972608